Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders.
Journal of medicinal chemistry
View this publicationJournal of medicinal chemistry
View this publicationNature communications
View this publicationAmerican journal of human genetics
View this publicationCell death & disease
View this publicationCell stem cell
View this publicationLeukemia
View this publicationCirculation. Cardiovascular interventions
View this publicationScientific reports
View this publicationCell metabolism
View this publicationMethods in enzymology
View this publication